Here are four things to know about the company’s stock:
• The company presently has an average rating of “buy” and a consensus target price of $28.24.
• Globus Medical has a 52-week low of $17.45 and a 52-week high of $27.14.
• The stock’s 50-day moving average is $24.44 and its 200-day moving average is $22.
• The company has a market cap of $2.2 billion.
More articles on devices:
NuVasive’s 2014 revenue up 11.3% — 10 key notes
Medtronic Spine to honor Dr. Kenneth Robinson
ChoiceSpine brings former Alphatec, TranS1 execs onboard — 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
